Intermittent Theta Burst Stimulation (iTBS) for Emotion Regulation in Bipolar Disorder
Part of paid clinical trials in Charlestown, Massachusetts.
- Sponsor
- Massachusetts General Hospital
- Study ID
- NCT06274567
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 24 Years - 65 Years
- Healthy Volunteers
- Not accepted
Interventions
- Transcranial Magnetic Stimulation (TMS) — DEVICETranscranial magnetic stimulation (TMS) is a non-invasive tool for modulating patterns of brain activation and circuit connectivity. It uses electromagnetic pulses to induce electric currents over the cortex that serve to depolarize or hyperpolarize neurons, thereby changing patterns of synaptic activity. This study uses intermittent theta burst stimulation (iTBS), an efficient TMS protocol that uses high frequency (50Hz) triplets of TMS given every 200 milliseconds (i.e. at 5 Hz).
- Sham (placebo) TMS — DEVICESham stimulation works by blocking the magnetic field with an internal spacer on the sham side of the TMS coil, allowing the operator to place the coil surface against the scalp. A brief electric pulse calibrated to the stimulator output is delivered to the scalp simultaneous to the TMS pulse to mimic the scalp sensation during the sham condition. 75 Importantly, the electric pulse is calibrated to the stimulator output to ensure a realistic sham condition.
Study Details
The objective of this study protocol is to test whether intermittent theta-burst transcranial magnetic stimulation (iTBS-TMS) to the inferior parietal lobule (IPL) can strengthen functional connectivity with a key region in emotion regulation (ER) neurocircuitry (anterior insula, AI) and improve performance on ER-related tasks in patients with bipolar disorder. Individual IPL sites for stimulation will be identified through baseline, pre-TMS functional magnetic resonance imaging (fMRI) scans. Patient-specific IPL subregions showing positive functional connectivity with the anterior insula and falling within the patient-specific frontoparietal control network will be used as individualized target sites for TMS stimulation. Patients will be randomized to receive 24 sessions of active versus sham iTBS to patient-specific IPL targets (6 sessions/day, 4 days, 43,200 pulses total). Post-iTBS resting-state and task-based fMRI scans will be acquired 3 days after the final day of iTBS administration (Day 4) following identical procedures as baseline. Effects of iTBS-TMS on ER will be evaluated by comparing pre-TMS versus post-TMS functional connectivity and behavior during performance on ER tasks.
Key Dates
- Start date
- Sep 20, 2024
- Status verified
- Apr 2025
- Primary completion
- Feb 28, 2029
- Completion
- Mar 31, 2029
Study Design
- Enrollment
- 136 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Active intermittent theta burst stimulation (iTBS)The Active intermittent theta burst stimulation (iTBS) arm will receive active iTBS applied to the inferior parietal lobule (IPL)
- Placebo Comparator: Sham intermittent theta burst stimulation (iTBS)The Sham intermittent theta burst stimulation (iTBS) arm will receive sham iTBS applied to the inferior parietal lobule (IPL)
Primary Outcome Measure
Correlated functional magnetic resonance imaging (fMRI) time series (functional connectivity) [ Time Frame: Baseline, 1-3 days post 4-day intervention (up to 4 weeks post Baseline) ]
Central Contacts
- Kristen K Ellard, PhD617-724-3221
- Christopher Polanco, MS MBA(617) 643-2776
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Martinos Center for Biomedical Imaging | Charlestown | Massachusetts | 02129 | Kristen K Ellard, PhD (PRINCIPAL_INVESTIGATOR) |
| University of Pennsylvania, Center for Neuromodulation in Depression and Stress | Philadelphia | Pennsylvania | 19104-4283(215) 573-4229 | Walid Makhoul, MD Yvette Sheline, MD, MS (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Charlestown, MA
Related Studies
- BezafibrateTreatment for Bipolar Depression: A Proof of Concept StudyPHASE2 · Recruiting · Massachusetts General Hospital · Boston, Massachusetts
- Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric PopulationsRecruiting · Massachusetts General Hospital · Boston, Massachusetts
- Children's Bipolar Network Treatment Trial IRecruiting · University of California, Los Angeles · Los Angeles, California
- Assessing the Impact of Cannabidiol for Anxiety and Depression in Bipolar DisorderPHASE2 · Recruiting · Mclean Hospital · Belmont, Massachusetts